6 Results for "

SUM149 cell

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "SUM149 cell" in MCE Product Catalog:

9
9 Cited Publications
Cat. No.: HY-Q45780
CAS No.: 667880-11-7
Target:  

Akt

Research Areas:  

Cancer

ZINC00640089 is a specific Lipocalin-2 (LCN2) inhibitor. ZINC00640089 inhibits cell proliferation, cell viability and reduces AKT phosphorylation levels in SUM149 cells. ZINC00640089 has good potential for research in inflammatory breast cancer (IBC) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-148364
CAS No.: 317328-17-9
Purity:  99.96%
Target:  

Lipocalin Family Akt

Research Areas:  

Cancer

ZINC00784494 is a specific Lipocalin-2 (LCN2) inhibitor. ZINC00784494 inhibits cell proliferation, cell viability and reduces AKT phosphorylation levels in SUM149 cells. ZINC00784494 has good potential for research in inflammatory breast cancer (IBC) .
loading...
    loading...
Cat. No.: HY-107551
CAS No.: 599150-20-6
Purity:  ≥95%
Target:  

Hedgehog Gli

Research Areas:  

Cancer

Hh Pathway-IN-1, a Hedgehog (Hh) pathway inhibitor, is a potent Gli antagonist. Hh Pathway-IN-1 inhibits Hh pathway functional with an IC50 value of 1.1 µM in C3H10T1/2 cells. Hh Pathway-IN-1 does not inhibit Wnt signaling. Hh Pathway-IN-1 shows anti-proliferative activity. Hh Pathway-IN-1 decreases the GLI1 mRNA expression. Hh Pathway-IN-1 inhibits colony formation in a dose-dependent manner .
loading...
    loading...
Cat. No.: HY-164959
CAS No.: 300816-12-0
Target:  

Lipocalin Family

Research Areas:  

Cancer

ZINC00230567 is an inhibitor for Lipocalin-2 (LCN2). ZINC00230567 reduces the colony formation and cell viability of cell SUM149, and exhibits anti-tumor efficacy .
loading...
    loading...
Cat. No.: HY-161934
Research Areas:  

Cancer

PARP1-IN-27 (Compound 9B) is the inhibitor for PARP1 and PARP2, with IC50 of 2.53 nM and 6.45 nM in cell SUM149PT. PARP1-IN-27 inhibits the proliferation of BRCA-mutated cancer cells SUM149PT, HCC1937 and Capan-1, with IC50 of 0.62, 1.91 and 4.26 μM respectively. PARP1-IN-27 aggravates DNA double-strand breaks, increases ROS generation, arrests cell cycle at G2/M phase, and induces apoptosis in SUM149PT .
loading...
    loading...
Cat. No.: HY-P11888
CAS No.: 1886065-39-9
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

DK 221 is a PD-L1 blocker with an IC50 of 24.5 nM for inhibiting the binding of PD-L1 to PD-1. DK 221 reduces the uptake of [ 18F]DK222 in PD-L1-positive tumor cells and mouse xenografts. DK 221 is applicable to research related to triple-negative breast cancer and melanoma .
loading...
    loading...